ArticleACS medicinal chemistry letters2025

Targeting KRAS G12D Mutations: Advances in Small Molecule Inhibitors and PROTAC Technology.

Robert B KargboPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.